Muscle–glucose trade-offs in metabolic aging: a dynamical-systems model of an interior optimal dose for glucose-lowering interventions

Manuscript prepared for Theory in Biosciences. Status. Theoretical and computational study. No human or animal data were used and no parameter was fitted; every result is conditional on the assumptions tabulated in the paper. What it shows. A latent information-loss variable, a muscle reserve and an energy-storage compartment are coupled through circulating glucose (quasi-steady state); one dose lowers glucose, removes lean mass and reduces storage. At the nominal parameters information loss at age 75 is U-shaped in dose with a minimum at u* = 0.39. The slope of the dose–response splits exactly into glucose, storage and muscle pathways, and a stationarity condition relates the optimum to the ratio of the muscle and glucose aging couplings. An interior optimum is present in 57% of 40,000 sampled parameterizations (39–69% across five sampling priors; 26–58% across treatment horizons of 5 to 30 years); it requires a muscle-deficit cost and a threshold-like muscle-loss response. An adiposity penalty deepens the benefit but moves the nominal optimum by less than 0.02. The index SIM overstates the benefit relative to information loss (metabolic age 67.0 against 72.8 years). The ratio of couplings that controls the optimum is only weakly constrained by glucose, muscle and storage measurements (information gain 0.37 in the best dose-ranging design examined). A dose-ranging experiment that would refute the model is specified. Nothing here is a dosing recommendation. Code, results and the scripts that regenerate every number: https://github.com/sandlerleon/aging-information-loss.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-15
DOI
https://doi.org/10.5281/zenodo.24250659
Primary Topic
Diabetes Treatment and Management
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Muscle–glucose trade-offs in metabolic aging: a dynamical-systems model of an interior optimal dose for glucose-lowering interventions

Leon Sandler
Zenodo (CERN European Organization for Nuclear Research)
Diabetes Treatment and Management
preprint

Muscle–glucose trade-offs in metabolic aging: a dynamical-systems model of an interior optimal dose for glucose-lowering interventions

Leon Sandler
preprint en

Abstract

Manuscript prepared for Theory in Biosciences. Status. Theoretical and computational study. No human or animal data were used and no parameter was fitted; every result is conditional on the assumptions tabulated in the paper. What it shows. A latent information-loss variable, a muscle reserve and an energy-storage compartment are coupled through circulating glucose (quasi-steady state); one dose lowers glucose, removes lean mass and reduces storage. At the nominal parameters information loss at age 75 is U-shaped in dose with a minimum at u* = 0.39. The slope of the dose–response splits exactly into glucose, storage and muscle pathways, and a stationarity condition relates the optimum to the ratio of the muscle and glucose aging couplings. An interior optimum is present in 57% of 40,000 sampled parameterizations (39–69% across five sampling priors; 26–58% across treatment horizons of 5 to 30 years); it requires a muscle-deficit cost and a threshold-like muscle-loss response. An adiposity penalty deepens the benefit but moves the nominal optimum by less than 0.02. The index SIM overstates the benefit relative to information loss (metabolic age 67.0 against 72.8 years). The ratio of couplings that controls the optimum is only weakly constrained by glucose, muscle and storage measurements (information gain 0.37 in the best dose-ranging design examined). A dose-ranging experiment that would refute the model is specified. Nothing here is a dosing recommendation. Code, results and the scripts that regenerate every number: https://github.com/sandlerleon/aging-information-loss.

Zenodo (CERN European Organization for Nuclear Research)
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon